RecruitingNCT06723938

Phenotypic and Genotypic Characterisation of a Large, Multicentre Italian Cohort of 46, XY DSD Patients

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

520 participants

Start Date

Jun 15, 2021

Study Type

OBSERVATIONAL

Conditions

46, XY DSD

Summary

Observational exploratory study of a cohort of pediatric and adolescent patients diagnosed with DSD karyotype 46,XY, a rare congenital clinical condition characterized by a disharmonic development between chromosomal sex, gonadal sex and/or phenotypic sex.

Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with 46, xy dsd. The study is currently recruiting participants at 4 locations. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(4)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, Italy

IRCCS Ospedale San Raffaele

Milan, Milano, Italy

Azienda Ospedaliero Universitaria Pisana

Pisa, Pisa, Italy

Ospedale Pediatrico Bambino Gesù

Roma, Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06723938

Related Trials

GROWing Up With Rare GENEtic Syndromes

NCT044633161 location